Viewing Study NCT01392235


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2025-12-25 @ 7:49 PM
Study NCT ID: NCT01392235
Status: COMPLETED
Last Update Posted: 2019-01-22
First Post: 2011-07-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module